These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9518687)

  • 1. Quinpirole attenuates the striatal fos expression induced by escape behavior.
    Struthers WM; Wirtshafter D
    Brain Res; 1998 Mar; 785(2):347-50. PubMed ID: 9518687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Thomas LI
    Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists.
    Cook DF; Wirtshafter D
    Eur J Pharmacol; 1998 May; 349(1):41-7. PubMed ID: 9669494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Strauss JB
    Brain Res; 1999 May; 827(1-2):160-8. PubMed ID: 10320705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D(1) dopamine receptors in the rat.
    Wirtshafter D; Asin KE
    Brain Res; 2001 Mar; 893(1-2):202-14. PubMed ID: 11223008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats.
    Wirtshafter D; Schardt G; Asin KE
    Brain Res; 1997 Oct; 771(2):271-7. PubMed ID: 9401747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of NMDA glutamate receptors in regulating D2 dopamine-dependent Fos induction in the rat striatopallidal pathway.
    Pollack AE; Bird JL; Lambert EB; Florin ZP; Castellar VL
    Brain Res; 1999 Feb; 818(2):543-7. PubMed ID: 10082844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum.
    Wirtshafter D; Asin KE
    Brain Res Bull; 1994; 35(1):85-91. PubMed ID: 7953762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinpirole attenuates the striatal immediate early gene expression, but not the hyperactivity, induced by the serotonin agonist RU-24969.
    Cook DF; Wirtshafter D
    Brain Res; 2000 Jan; 852(2):247-54. PubMed ID: 10678749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
    Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
    Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Fink JS
    Brain Res; 1996 Dec; 743(1-2):124-30. PubMed ID: 9017239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres.
    Marshall JF; Cole BN; LaHoste GJ
    Brain Res; 1993 Dec; 632(1-2):308-13. PubMed ID: 7908600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
    Asin KE; Bednarz L; Nikkel A; Perner R
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1483-90. PubMed ID: 7791123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats.
    Ruskin DN; Marshall JF
    Brain Res; 1995 Dec; 703(1-2):156-64. PubMed ID: 8719628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive effects of stimulation of D1 and D2 dopamine receptors on Fos expression in the lateral habenula.
    Wirtshafter D; Krebs JC
    Brain Res; 1997 Mar; 750(1-2):245-50. PubMed ID: 9098550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCH 23390-induced behavioral supersensitivity is not related to striatal c-fos levels.
    Muñoz JE; Marín C; Tolosa E
    Brain Res; 1997 Nov; 774(1-2):51-4. PubMed ID: 9452191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.